Cargando…

When should antiretroviral therapy be started in HIV-positive persons?

Recommendations for the initiation of combination antiretroviral therapy in HIV-positive individuals are largely based on data from observational studies. Whilst all guidelines recommend immediate treatment in individuals with a CD4 count of less than 350 cells/mm(3), guidelines vary in their recomm...

Descripción completa

Detalles Bibliográficos
Autor principal:	Sabin, Caroline A
Formato:	Texto
Lenguaje:	English
Publicado:	Faculty of 1000 Ltd 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998833/ https://www.ncbi.nlm.nih.gov/pubmed/21170371 http://dx.doi.org/10.3410/M2-81

Ejemplares similares

When Should Children with HIV Infection Be Started on Antiretroviral Therapy?
por: Welch, Steven B, et al.
Publicado: (2008)

When to Start Antiretroviral Therapy
por: Jain, Vivek, et al.
Publicado: (2010)

Cryptococcal meningoencephalitis in HIV/AIDS: when to start antiretroviral therapy?
por: Franco-Paredes, Carlos, et al.
Publicado: (2017)

When to start antiretroviral therapy: as soon as possible
por: Franco, Ricardo A, et al.
Publicado: (2013)

Antiretroviral therapy in Indian setting: When & what to start with, when & what to switch to?
por: Kumarasamy, N., et al.
Publicado: (2011)

When to start antiretroviral therapy: the need for an evidence base during early HIV infection
por: Lundgren, Jens D, et al.
Publicado: (2013)

CD4+:CD8+ T Cell Ratio Normalization and the Development of AIDS Events in People with HIV Starting Antiretroviral Therapy
por: Okhai, Hajra, et al.
Publicado: (2020)

When should treatment be started for hypertension?
Publicado: (2019)

Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy?
por: Sabin, Caroline A
Publicado: (2013)

When to start and when to stop antifibrotic therapies
por: Torrisi, Sebastiano Emanuele, et al.
Publicado: (2017)

Pregnancy is associated with elevation of liver enzymes in HIV-positive women on antiretroviral therapy
por: Huntington, Susie, et al.
Publicado: (2015)

HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?
por: Kulpa, Deanna A, et al.
Publicado: (2015)

T42. WHEN SHOULD EARLY INTERVENTION START, AND FOR HOW LONG SHOULD IT LAST?
por: Albert, Nikolai, et al.
Publicado: (2018)

When to start antiretroviral therapy in resource-limited settings: a human rights analysis
por: Ford, Nathan, et al.
Publicado: (2010)

The science of rapid start—From the when to the how of antiretroviral initiation
por: Geng, Elvin H., et al.
Publicado: (2017)

Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy
por: Trickey, Adam, et al.
Publicado: (2016)

Dialysis Should Be Started When Absolutely Necessary, Not Early and Incrementally
por: Rosansky, Steven Jay
Publicado: (2017)

When should screening of pediatric trauma patients for adult behaviors start?
por: Maung, Adrian A, et al.
Publicado: (2018)

Locoregional therapy in hepatocellular carcinoma: when to start and when to stop and when to revisit
por: Lee, J.J.X., et al.
Publicado: (2021)

Realizing a desired family size: when should couples start?
por: Habbema, J. Dik F., et al.
Publicado: (2015)

Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
Publicado: (2017)

Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapy
por: Jose, Sophie, et al.
Publicado: (2014)

Effects of Undernutrition and Predictors on the Survival Status of HIV-Positive Children after Started Antiretroviral Therapy (ART) in Northwest Ethiopia
por: Molla, Mulugeta, et al.
Publicado: (2022)

Appropriate Time to Start Antiretroviral Therapy in HIV-infected Patients with Penicilliosis marneffei
por: Utkham, Thongchai, et al.
Publicado: (2017)

Life expectancy of HIV-1-positive individuals approaches normal conditional on response to antiretroviral therapy: UK Collaborative HIV Cohort Study
por: May, M, et al.
Publicado: (2012)

When to start aripiprazole therapy in patients with bipolar mania
por: Sayyaparaju, Kiran Kumar, et al.
Publicado: (2014)

Incidence of Severe Neutropenia in HIV-Infected People Starting Antiretroviral Therapy in West Africa
por: Leroi, Charline, et al.
Publicado: (2017)

Retention in Care of HIV-Infected Children from HIV Test to Start of Antiretroviral Therapy: Systematic Review
por: Mugglin, Catrina, et al.
Publicado: (2013)

Incidence of and risk factors for tuberculosis among people with HIV on antiretroviral therapy in the United Kingdom
por: van Halsema, Clare L., et al.
Publicado: (2020)

Personality neuroscience and psychopathology: should we start with biology and look for neural-level factors?
por: McNaughton, Neil
Publicado: (2020)

1039. Real World Community-Based HIV Rapid Start Antiretroviral with BFTAF Versus Conventional HIV Antiretroviral Therapy Start – The RoCHaCHa Study, a Pilot Study
por: Zuppelli, Ashley R, et al.
Publicado: (2020)

What is the optimum time to start antiretroviral therapy in people with HIV and tuberculosis coinfection? A systematic review and meta‐analysis
por: Burke, Rachael M, et al.
Publicado: (2021)

Tuberculosis treatment intermittency in the continuation phase and mortality in HIV-positive persons receiving antiretroviral therapy
por: Crabtree-Ramirez, Brenda, et al.
Publicado: (2022)

When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational Study
por: Caniglia, Ellen C., et al.
Publicado: (2016)

Central Nervous System Strongyloidiasis and Cryptococcosis in an HIV-Infected Patient Starting Antiretroviral Therapy
por: Rodríguez, Mónica, et al.
Publicado: (2012)

Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy
por: Yiannoutsos, Constantin Theodore, et al.
Publicado: (2012)

Treatment modification in HIV-Infected individuals starting antiretroviral therapy between 2011 and 2014
por: Rappold, Michaela, et al.
Publicado: (2014)

Impact of nutritional supplementation on immune response, body mass index and bioelectrical impedance in HIV-positive patients starting antiretroviral therapy
por: Evans, Denise, et al.
Publicado: (2013)

Who Starts? Factors Associated with Starting Antiretroviral Therapy among Eligible Patients in Two, Public HIV Clinics in Lilongwe, Malawi
por: Feldacker, Caryl, et al.
Publicado: (2012)

Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV‐Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial
por: Baker, Jason V., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vgdmaobof30250iuqgbv2t4lvp